Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

What Rheumatologists Are Paid

Richard Quinn  |  July 28, 2017

A 2017 survey showed that rheumatologists’ pay has plateaued. And according to Anne Bass, MD, many cognitive fields, such as pediatrics and endocrinology, remain underpaid due to the current reimbursement structure…

As Drug Prices Drop, Generics Makers Fight Back with Deals

Carl O'Donnell  |  July 27, 2017

NEW YORK (Reuters)—Generic drug makers are turning to mergers and acquisitions to shield themselves against a concerted effort by U.S. regulators to crack down on steep drug prices. Impax Laboratories Inc, Perrigo Company Plc and Alvogen Inc have been talking to advisers about strategic options for their generics businesses, ranging from acquisitions to increase scale…

U.S. Senate Mulls Bare-Bones Healthcare Bill; Marathon of Voting Expected

Yasmeen Abutaleb and Susan Cornwell  |  July 27, 2017

WASHINGTON (Reuters)—U.S. Senate Republicans embarked on Thursday on another push to unravel Obamacare, working on a stripped-down bill after failing to pass broader legislation and complete a seven-year campaign to gut a law that extended health coverage to millions. Republicans leaders hope a so-called skinny bill can draw enough votes to pass despite unified Democratic…

U.S. Senator Expands Opioid Probe to Distributors, Drugmakers

Reuters Staff  |  July 27, 2017

(Reuters)—U.S. Democratic Senator Claire McCaskill on Thursday expanded an investigation into the causes of the opioid crisis plaguing the country, seeking information from four more drugmakers and three drug distributors. The top-ranking Democrat on the Senate Homeland Security and Governmental Affairs Committee is focusing on the distribution of opioids and the efforts companies made to…

U.S. Senate Rejects Obamacare Repeal Again, Eyes a ‘Skinny’ Bill

Susan Cornwell and Yasmeen Abutaleb  |  July 27, 2017

WASHINGTON (Reuters)—Republicans in the U.S. Senate fell short again on Wednesday in their effort to end Obamacare, rejecting a measure to repeal large portions of President Barack Obama’s signature law that has provided health insurance to millions of Americans. But Republican Senate leaders, struggling to keep a seven-year-old promise to unravel the law, already were…

Anthem May Exit More Individual Markets over Obamacare Funding

Caroline Humer  |  July 26, 2017

(Reuters)—Anthem Inc. said it may leave more individual Obamacare markets due to uncertainty about the potential repeal of the healthcare law and subsidies that make the plans affordable for millions of Americans. Republicans on Tuesday began a second day of debate on the U.S. Senate floor of a bill that would end Obamacare, but the…

Obamacare Repeal Battle Back on Senate Floor

Richard Cowan  |  July 26, 2017

WASHINGTON (Reuters)—After a months-long struggle, Republicans have succeeded in bringing Obamacare repeal legislation, a centerpiece of their 2016 election campaigns, to a debate on the U.S. Senate floor. Now the hard part begins. Republicans, deeply divided over the proper role of the government in helping low-income people receive healthcare, eked out a procedural win on…

McCain to Return for Pivotal U.S. Senate vote on Healthcare

James Oliphant  |  July 25, 2017

WASHINGTON (Reuters)—Sen. John McCain (R-Az.) will return to the U.S. capitol on Tuesday to play what could be a crucial role in salvaging Republican efforts to repeal Obamacare and keep their years-long pledge to unwind the 2010 healthcare overhaul. McCain, who is battling brain cancer, is set to help decide whether the repeal push will…

Republicans’ Push to Roll Back Obamacare Faces Crucial test

Ayesha Rascoe & Amanda Becker  |  July 25, 2017

WASHINGTON (Reuters)—President Donald Trump pleaded with U.S. Senate Republicans on Monday to “do the right thing” on healthcare and allow debate to begin on a measure to repeal and replace Obamacare. The Senate is expected to vote on Tuesday on whether to begin debating a healthcare overhaul, although Senate Majority Leader Mitch McConnell (R-Ky.) has…

Collaborative Guideline Addresses the Perioperative Use of Antirheumatic Drug Therapy

Arthritis & Rheumatology  |  July 25, 2017

A new guideline developed by the ACR and the American Association of Hip and Knee Surgeons addresses the perioperative use of antirheumatic drug therapy. Specifically, it provides recommendations on the use of traditional disease-modifying antirheumatic drugs, biologic agents, tofacitinib and glucocorticoids in adults with RA; SpA, including ankylosing spondylitis and psoriatic arthritis; JIA; or SLE undergoing elective THA or TKA. The guideline provides recommendations regarding when to continue, when to withhold and when to restart these medications, and the optimal perioperative dosing of glucocorticoids…

  • « Previous Page
  • 1
  • …
  • 410
  • 411
  • 412
  • 413
  • 414
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences